Rapidly Growing Hand Nodule

June 2021 in “ The Journal of Family Practice ”

Stulberg

alopecia areata keratoacanthoma squamous cell carcinoma curettage electrodesiccation KA SCC

TLDR A 69-year-old woman has a fast-growing hand lesion that didn't improve with salicylic acid.

A 69-year-old woman with alopecia areata presented with a rapidly growing lesion on her hand, which was diagnosed as a keratoacanthoma (KA), a subtype of squamous cell carcinoma (SCC). KAs are characterized by large, firm, erythematous nodules with central keratin plugs and can grow quickly. The lesion was treated with curettage and electrodesiccation, and pathology confirmed it as a KA type of SCC. At a 6-week follow-up, the area was healing well with no recurrence.

View this study on mdedge.com →

Discuss this study in the Community →

Related Community Posts Join

6 / 1000+ results

community Alopecia Areata Question

in Treatment 2 upvotes 3 years ago

A user with alopecia totalis, borderline universalis, seeks advice on getting into a Xeljanz trial or appealing insurance for coverage. They experienced significant hair regrowth but are now seeing hair loss again and want to try Xeljanz.

community mbp alopecia areata or vitamin deficiency

in Chat 3 months ago

A 19-year-old male has been using topical finasteride and minoxidil for 8 months with no progress and is considering seeking a second opinion due to potential misdiagnosis. The discussion revolves around whether the hair loss is due to male pattern baldness, alopecia areata, or a vitamin deficiency.

community Olumiant alternative for Alopecia Areata?

in Treatment 1 upvotes 1 year ago

A user with alopecia areata is considering treatment options like injections or Olumiant but is concerned about cost and whether delaying treatment will lead to permanent hair loss. They are seeking alternative treatments that are more affordable for a college student.

community Covid (likely) induced alopecia areata - now 2nd round of Covid, what can I expect?

in Treatment 1 upvotes 1 year ago

After experiencing hair loss due to alopecia areata following COVID-19 vaccination and infection, the individual saw improvement with steroid treatments and Olumiant. They paused Olumiant during a second COVID-19 infection and expressed concern about potential hair loss flare-ups.

community Onion Juice - An effective topical treatment for Alopecia Areata 🧬

in Treatment 1 year ago

Onion juice, when applied topically, is an effective treatment for Alopecia Areata, showing significant hair regrowth in both males and females. The study suggests it could be interesting to test its effectiveness on Androgenic Alopecia.

community Nearly 40% of Adults with Alopecia Areata Taking OLUMIANT® 4-mg Saw at Least 80% Scalp Hair Coverage at 52 Weeks

in Research/Science 6 upvotes 2 years ago

Nearly 40% of adults with alopecia areata achieved at least 80% scalp hair coverage after 52 weeks of taking OLUMIANT® 4-mg. The conversation distinguishes this success from androgenetic alopecia, which is a different type of hair loss.

Similar Research

5 / 1000+ results

research Atlas of Geriatric Dermatology

2 citations, January 2014 in “Springer eBooks”

The book details skin conditions in older adults, their link to mental health, cancer treatment importance, hair loss remedies, and managing autoimmune and itchy skin.

research Skin Disorders

March 2012 in “Pathy's Principles and Practice of Geriatric Medicine”

Older adults often have skin problems due to aging, and treating these conditions requires attention to both physical and mental health.

research Subject Index

March 2014 in “Journal of The American Academy of Dermatology”

The document lists various dermatology topics, treatments, and diagnostic methods.

The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: The Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma

research The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: The Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma

6 citations, April 2013 in “Current Dermatology Reports”

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

research Index

January 2019